Lundbeck's departing head of North America, Peter Anastasiou, now reveals his new job title in a post on social media LinkedIn.
From January, he will join US-based biotech firm Capsida Biotherapeutics as its CEO, he announces in the statement.
More from MedWatch
Experiences from Danish climate partnerships are among the tools that can be leveraged when Novo Nordisk CEO Lars Fruergaard begins stepping up efforts in the life science sector’s central organs in Brussels. ”I’ve been fired up by the intimacy and shared vision we could see in Denmark,” he tells MedWatch.